» Articles » PMID: 1551546

Combined Nitrofurantoin Toxicity to Liver and Lung

Overview
Specialty Gastroenterology
Date 1992 Apr 1
PMID 1551546
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Nitrofurantoin is an antibiotic commonly used for prophylaxis and treatment of urinary tract infections. Pulmonary and hepatic toxicity are rare side effects of this agent. The simultaneous occurrence of pulmonary fibrosis and chronic active hepatitis in a patient undergoing long-term nitrofurantoin therapy is reported. The presence of pulmonary toxicity was evidenced by infiltrates on chest radiographs and impaired diffusion capacity during pulmonary function tests. Prolonged elevation of liver enzyme concentrations together with the presence of increased antibody titers (anti-smooth muscle antibody, antinuclear antibody) was suggestive of chronic hepatitis, a diagnosis corroborated by liver biopsy findings. After discontinuation of nitrofurantoin therapy, the patient had a full recovery. The infiltrates initially found on chest radiographs disappeared, and laboratory parameters normalized without the need for corticosteroid therapy.

Citing Articles

Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease.

Carvalho de Matos A, Macedo C, Afonso Mendes P, Cipriano M, Paiva A, Simao A GE Port J Gastroenterol. 2022; 29(4):273-279.

PMID: 35979248 PMC: 9274943. DOI: 10.1159/000516940.


Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.

Sherigar J, Fazio R, Zuang M, Arsura E Clin Pract. 2014; 2(4):e83.

PMID: 24765482 PMC: 3981194. DOI: 10.4081/cp.2012.e83.


Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.

Kiang T, Ford J, Yoshida E, Partovi N Can J Hosp Pharm. 2012; 64(4):262-70.

PMID: 22479069 PMC: 3161801. DOI: 10.4212/cjhp.v64i4.1039.


Autoimmune hepatitis triggered by nitrofurantoin: a case series.

Appleyard S, Saraswati R, Gorard D J Med Case Rep. 2010; 4:311.

PMID: 20863377 PMC: 2955056. DOI: 10.1186/1752-1947-4-311.


Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion.

Yue W, Abe K, Brouwer K Mol Pharm. 2008; 6(1):134-43.

PMID: 19105722 PMC: 3135650. DOI: 10.1021/mp800100e.